Eli Lilly wins FDA approval of donanemab for Alzheimer’s (NYSE:LLY)
jetcityimage/iStock Editorial via Getty Images The U.S. FDA has approved Eli Lilly's (NYSE:LLY) donanemab as a treatment for early Alzheimer's ...
jetcityimage/iStock Editorial via Getty Images The U.S. FDA has approved Eli Lilly's (NYSE:LLY) donanemab as a treatment for early Alzheimer's ...
Love Employee/iStock via Getty Images The international market for radiopharmaceuticals is expected to reach $13.67B by 2032, with a compound ...
Valerii Evlakhov/iStock via Getty Images Goldman Sachs spotlighted key healthcare themes to follow in 2023, noting a few days ago ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.